Duodenal neuroendocrine tumours in morbidly obese: Amalgamated strategy to optimise outcome

Nikhil Jain, Banshidhar Soni, Ashish Khetan, Siddharth Mishra, Bhuwanesh Sharma, Rajesh BhojwaniJournal of Minimal Access Surgery 2021 17(2):249-252The association of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) with obesity has been reported and researched on. Rendering of a laparoscopic treatment treating these concurring pathologies in unison has not been described. Two morbidly obese patients with duodenal NETs underwent a resectional procedure, with curative intent, in the form of laparoscopic subtotal gastrectomy with roux-en-y gastrojejunostomy with partial duodenectomy and a laparoscopic one-anastomosis gastric bypass-mini gastric bypass with remnant gastrectomy and partial duodenectomy. Both patients had an uneventful convalescence with acceptable weight loss and no evidence of tumour recurrence on follow-up. The indolent nature of NETs, as compared to the morbidity of obesity provides the rationale for treating this particular cohort of patients with a surgical procedure that would serve to remove the tumour and also provide therapeutic benefit for obesity. With experience in advanced laparoscopic procedures, this can be accomplished safely with acceptable results.
Source: Journal of Minimal Access Surgery - Category: Surgery Authors: Source Type: research